print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST
13/10/2014 (Added to site)
Author(s): Lekner, J.

Electroporation in cancer therapy without insertion of electrodes

Journal: Physics in Medicine and Biology, 59/20 (2014), pp. 6031-42
DOI: 10.1088/0031-9155/59/20/6031
Request reprint  |  Tell your friend  | 

Abstract: Electroporation in cancer therapy in which elongated micron-sized conductors are used to enhance an externally applied electric field is investigated. Such field enhancement was previously used in carbon and boron nitride nanotube electropermeabilization. It is envisaged that the micro-conductors would be injected together with therapeutic drugs into tumorous regions, and a pulsed or alternating external field would be applied. Amplification of this external electric field at the pointed ends of the elongated micro-conductors would then give (locally) a field sufficiently large to cause electroporation. The torque of the electric field on the polarized micro-conductors will tend to align them with the field, giving the configuration of maximum field enhancement at their ends. Brownian (thermal) motion will disrupt this alignment. We give an analysis of field enhancement, torque, and thermal motion for micro-conductors of prolate spheroidal shape, and estimate the range of their size for use in human tissue.


Keywords: cancer    electroporation    field enhancement   

Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: